This site is intended for U.S. Healthcare Professionals only.

Phase 3 Clinical Results

cUTI: RECAPTURE

AVYCAZ vs doripenem (N=1020)

A phase 3, multinational, multicenter, double-blind, randomized noninferiority trial studying AVYCAZ vs doripenem for the treatment of cUTI, including acute pyelonephritis and complicated lower urinary tract infections.1

cUTI, complicated urinary tract infections.

cUTI: REPRISE

AVYCAZ vs best available therapy (BAT; N=305)

A phase 3, multinational, randomized, open-label trial comparing AVYCAZ vs BAT for the treatment of cUTI due to ceftazidime-nonsusceptible Gram-negative pathogens. BAT options were meropenem, imipenem, doripenem, and colistin.1

cIAI: RECLAIM

AVYCAZ plus metronidazole vs meropenem (N=1058)

A phase 3, multinational, double-blind, noninferiority trial studying AVYCAZ plus metronidazole versus meropenem for the treatment of cIAI.1

cIAI, complicated intra-abdominal infections.